![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 3
2019
Harbeck, Nadia; Wang, Jessie; Otto, Gordon Philipp; Gattu, Sreekanth und Krendyukov, Andriy
(2019):
Safety analysis of proposed pegfilgrastim biosimilar in Phase I and Phase III studies.
In: Future Oncology, Bd. 15, Nr. 12: S. 1313-1322
2018
Harbeck, Nadia; Gascon, Pere; Krendyukov, Andriy; Hoebel, Nadja; Gattu, Sreekanth und Blackwell, Kimberly
(2018):
Safety Profile of Biosimilar Filgrastim (Zarzio/Zarxio): A Combined Analysis of Phase III Studies.
In: Oncologist, Bd. 23, Nr. 4: S. 403-409
2017
Harbeck, Nadia; Gascon, Pere; Jones, Clyde M.; Nixon, Allen; Krendyukov, Andriy; Nakov, Roumen; Li, Yuhan und Blackwell, Kimberly
(2017):
Proposed biosimilar pegfilgrastim (LA-EP2006) compared with reference pegfilgrastim in Asian patients with breast cancer: an exploratory comparison from two Phase III trials.
In: Future Oncology, Bd. 13, Nr. 16: S. 1385-1393